Evaluation of the Effect of Atorvastatin and Pioglitazone in Carotid Atherosclerosis With the Use of 18Fluoride-Fludeoxyglucose(FDG) Positron Emission Tomography-computed Tomography (PET-CT)Imaging.

Trial Profile

Evaluation of the Effect of Atorvastatin and Pioglitazone in Carotid Atherosclerosis With the Use of 18Fluoride-Fludeoxyglucose(FDG) Positron Emission Tomography-computed Tomography (PET-CT)Imaging.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Mar 2013

At a glance

  • Drugs Pioglitazone (Primary) ; Atorvastatin
  • Indications Atherosclerosis; Coronary artery disease
  • Focus Pharmacodynamics
  • Acronyms CUKCVC; PIONEER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 23 Nov 2012 Actual initiation date changed from June 2009 to June 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top